Prevalence and associated factors of perinatal asphyxia among newborns in Dilla University referral hospital, Southern Ethiopia– 2017
Received 28 November 2018
Accepted for publication 16 May 2019
Published 24 July 2019 Volume 2019:10 Pages 69—74
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Professor Roosy Aulakh
Abebe Alemu,1 Getnet Melaku,1 Gerezgiher Buruh Abera,2 Ashenafi Damte2
1Department of Midwifery, College of Health Science and Medicine, Dilla University, Dilla, Ethiopia; 2Department of Nursing, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia
Background: Globally, perinatal asphyxia is a significant contributing factor for neonatal morbidity and mortality. Thus, this study was aimed to assess the prevalence and associated factors with perinatal asphyxia among newborns in Dilla University referral hospital.
Methods: A cross-sectional study was conducted among newborns in Dilla University referral hospital, Ethiopia from February to April 2017. Systematic random sampling techniques were used to enroll a total of 262 study subjects. Multivariate logistic regression analysis was used to identify factors associated with the perinatal asphyxia among newborns.
Result: Of the newborns, 32.8% had perinatal asphyxia, and factors associated significantly were anemia during pregnancy (adjusted OR=2.99, 95%CI: 1.07–8.35), chronic hypertension (adjusted OR=4.89, 95%CI: 1.16–20.72), meconium-stained amniotic fluid (adjusted OR=3.59, 95%CI: 1.74–7.42), and low birth weight newborns (adjusted OR=3.31, 95%CI: 1.308–8.37).
Conclusion: Maternal anemia during pregnancy, chronic hypertension, meconium stained amniotic fluid, and low birth weight were significantly associated with perinatal asphyxia. Therefore, early screening and appropriate intervention during pregnancy, and intrapartum might reduce perinatal asphyxia among newborns.
Keywords: perinatal asphyxia, newborn, Dilla, Ethiopia
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]